Beijing Tiantan Biological Products Co., Ltd.

SHSE:600161 Stock Report

Market Cap: CN¥43.2b

Beijing Tiantan Biological Products Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Dao Xing Fu

Chief executive officer

CN¥2.9m

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership0.001%
Management average tenureno data
Board average tenure4.4yrs

Recent management updates

Recent updates

Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Oct 29
Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth

Oct 27
Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth

Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)

Oct 08
Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)

Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Shares May Have Run Too Fast Too Soon

Sep 19
Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Shares May Have Run Too Fast Too Soon

Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?

Jul 23
Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?

Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 09
Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value

Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings

May 22
Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings

We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt

Mar 16
We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt

Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?

Mar 01
Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?

CEO

Dao Xing Fu (58 yo)

4.4yrs

Tenure

CN¥2,888,600

Compensation

Mr. Dao Xing Fu serves as General Manager of Beijing Tiantan Biological Products Co., Ltd. and has been its Director since June 23, 2020. Mr. Fu served as Deputy General Manager at Beijing Tiantan Biologic...


Board Members

NamePositionTenureCompensationOwnership
Dao Xing Fu
GM & Director4.4yrsCN¥2.89m0.0013%
CN¥ 553.3k
Yanlin He
Deputy GM & Directorno dataCN¥1.91m0.0011%
CN¥ 479.8k
Yana Liu
Deputy GM & Director2.5yrsCN¥2.29m0.0017%
CN¥ 752.1k
Hui Chuan Yang
Chairman of the Board4.4yrsno data0.0024%
CN¥ 1.0m
Li Gang Hu
Director4.4yrsno data0.0011%
CN¥ 492.8k
Fenling Gu
Independent Director4.4yrsCN¥240.00kno data
Yan Fang
Independent Director4.4yrsCN¥240.00kno data
Jianming Wang
Employee Supervisor4.4yrsno data0.00056%
CN¥ 242.1k
Tan Cheng
Supervisor2.5yrsno datano data
Jian Chen
Chairman of the Supervisory Board1.5yrsno datano data

4.4yrs

Average Tenure

53.5yo

Average Age

Experienced Board: 600161's board of directors are considered experienced (4.4 years average tenure).